Cargando…
COVID-19 cardiac injury and the use of colchicine
We report a case of cardiac injury in a 46-year-old man affected by COVID-19. The patient presented with shortness of breath and fever. ECG revealed sinus tachycardia with ventricular extrasystoles and T-wave inversion in anterior leads. Troponin T and N-terminal pro B-type natriuretic peptide were...
Autores principales: | Anton-Vazquez, Vanesa, Byrne, Laura, Anderson, Lisa, Hamzah, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907860/ https://www.ncbi.nlm.nih.gov/pubmed/33622757 http://dx.doi.org/10.1136/bcr-2020-241047 |
Ejemplares similares
-
Preliminary results of clinical use of colchicine in COVID-19 treatment
por: Knack, Rafael Silvestre, et al.
Publicado: (2021) -
Colchicine plus Dapsone in Colchicine‐Resistant FMF Patients
por: Salehzadeh, Farhad, et al.
Publicado: (2019) -
Colchicine reduced pericardial effusion due to postcardiac injury syndrome following cardiac resynchronization therapy implantation
por: Hoshiyama, Tadashi, et al.
Publicado: (2017) -
COVID-19 in patients with gout on colchicine
por: Pelechas, Eleftherios, et al.
Publicado: (2021) -
The Ugly Side of Colchicine
por: Cozza, Justin, et al.
Publicado: (2021)